Felicia Falvo is a pharmacist who is specialized in Oncology in Milwaukee, Wisconsin. Patients can reach her at 9200 W Wisconsin Ave, Milwaukee or contact her on 414-805-2682. Active license number of Felicia Falvo is 16495-40 for Oncology in Wisconsin. Felicia Falvo is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Felicia Falvo speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Felicia Falvo
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Female
Location:
9200 W Wisconsin Ave, Milwaukee, Wisconsin, 53226-3522
Phone:
414-805-2682
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Felicia Falvo are as mentioned below.
NPI Number:
1053685909
NPI Enumeration Date:
23 Feb, 2012
NPI Last Update On:
23 Feb, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Felicia Falvo are as mentioned below.
Specialization
License Number
State
Status
Oncology
16495-40
Wisconsin
Primary
Pharmacist
RP445017
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9200 W Wisconsin Ave, Milwaukee, Wisconsin
Zip:
53226-3522
Phone Number:
--
Fax Number:
--
Patients can reach Felicia Falvo at 9200 W Wisconsin Ave, Milwaukee, Wisconsin or can call on phone at 414-805-2682.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.